Conquering Diseases

Receptos 3204: Continuing Study of an Investigational Drug for Moderate to Severe Crohn's disease.

Description

This study is for patients diagnosed with moderately to severely active Crohn’s disease who have recently completed a research study with the study drug.

Overview

Crohn’s Disease is a chronic inflammatory disorder of the bowels that can cause diarrhea, abdominal pain, rectal bleeding, weight loss, and fever. The purpose of this study is to see whether the investigational study drug is safe and effective for the possible treatment. If you join this research, you will be randomly assigned to receive either the study drug or placebo (a pill with inactive ingredients). Patients must have recently completed a previous study with this drug to participate.

What we're hoping for

We hope the study drug is safe and effective for long term treatment of Crohn’s Disease compared to a placebo (a pill that does not contain active ingredients).

Additional Information

ClinicalTrials.gov Identifier: NCT03467958

 Principal Investigator

David  Cave, MD

UMass Memorial Health Care

 Study Contact

The Gastrointestinal Research  Office

774-442-4098

IBDClinicalTrials@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989